These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 22035285

  • 21. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B, Kaufmann R, Talarico S, Torres Lozada V, Rodríguez-Castellanos MA, Gómez-Flores M, De Maubeuge J, Berg M, Foley P, Sysa-Jedrzejowska A, Kerrouche N, Paliargues F, Bettoli V.
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne.
    Kircik LH, Gwazdauskas J, Butners V, Eastern J, Green LJ.
    J Drugs Dermatol; 2013 Mar; 12(3):259-64. PubMed ID: 23545906
    [Abstract] [Full Text] [Related]

  • 23. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
    Schaller M, Sebastian M, Ress C, Seidel D, Hennig M.
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
    [Abstract] [Full Text] [Related]

  • 24. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
    Hayashi N, Kurokawa I, Siakpere O, Endo A, Hatanaka T, Yamada M, Kawashima M.
    J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
    [Abstract] [Full Text] [Related]

  • 25. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF, Draelos Z, Lucky AW, Hebert AA, Sugarman J, Stein Gold L, Rudisill D, Liu H, Manna V.
    J Drugs Dermatol; 2013 Jun 01; 12(6):611-8. PubMed ID: 23839175
    [Abstract] [Full Text] [Related]

  • 26. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
    Harper JC.
    J Drugs Dermatol; 2012 Dec 01; 11(12):1440-5. PubMed ID: 23377514
    [Abstract] [Full Text] [Related]

  • 27. A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris.
    Gern A, Walter J, Xu S, Vakharia PP.
    Arch Dermatol Res; 2024 May 24; 316(6):230. PubMed ID: 38787441
    [Abstract] [Full Text] [Related]

  • 28. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
    Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D.
    J Am Acad Dermatol; 2008 Nov 24; 59(5):792-800. PubMed ID: 18805603
    [Abstract] [Full Text] [Related]

  • 29. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R, Landi F, Milani M, Amerio P.
    Br J Dermatol; 2004 Aug 24; 151(2):481-4. PubMed ID: 15327558
    [Abstract] [Full Text] [Related]

  • 30. How patients experience and manage dryness and irritation from acne treatment.
    Feldman SR, Chen DM.
    J Drugs Dermatol; 2011 Jun 24; 10(6):605-8. PubMed ID: 21637901
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
    Bucks D, Sarpotdar P, Yu K, Angel A, Del Rosso J.
    J Drugs Dermatol; 2009 Jul 24; 8(7):634-8. PubMed ID: 19588639
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
    Poulin Y, Sanchez NP, Bucko A, Fowler J, Jarratt M, Kempers S, Kerrouche N, Dhuin JC, Kunynetz R.
    Br J Dermatol; 2011 Jun 24; 164(6):1376-82. PubMed ID: 21457209
    [Abstract] [Full Text] [Related]

  • 35. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L, Weiss J, Rueda MJ, Liu H, Tanghetti E.
    Am J Clin Dermatol; 2016 Jun 24; 17(3):293-303. PubMed ID: 26945741
    [Abstract] [Full Text] [Related]

  • 36. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
    NilFroushzadeh MA, Siadat AH, Baradaran EH, Moradi S.
    Indian J Dermatol Venereol Leprol; 2009 Jun 24; 75(3):279-82. PubMed ID: 19439881
    [Abstract] [Full Text] [Related]

  • 37. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH, Fouladi RF.
    J Drugs Dermatol; 2013 Jul 01; 12(7):790-4. PubMed ID: 23884492
    [Abstract] [Full Text] [Related]

  • 38. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graeber M, Adapalene-BPO Study Group.
    Br J Dermatol; 2009 Nov 01; 161(5):1180-9. PubMed ID: 19466959
    [Abstract] [Full Text] [Related]

  • 39. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W.
    Cutis; 2012 Aug 01; 90(2):91-6. PubMed ID: 22988653
    [Abstract] [Full Text] [Related]

  • 40. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
    Webster G, Thiboutot DM, Chen DM, Merikle E.
    Cutis; 2010 Nov 01; 86(5):263-7. PubMed ID: 21214129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.